SKF 97574
Alternative Names: B9937-051; BY 574Latest Information Update: 21 Jan 2008
At a glance
- Originator GlaxoSmithKline
- Developer ALTANA Pharma; GlaxoSmithKline
- Class Antiulcers; Gastric antisecretories
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 21 Jan 2008 Discontinued for Peptic ulcer in Germany (unspecified route)
- 16 Dec 1999 No-Development-Reported for Peptic ulcer in Germany (Unknown route)
- 14 Oct 1994 Discontinued-I for Peptic ulcer in USA (Unknown route)